Industries > Pharma > Neuromodulation Devices: World Market Prospects 2013-2023

Neuromodulation Devices: World Market Prospects 2013-2023

PUBLISHED: 02 January 2013
PAGES: 125
PRODUCT CODE:

Clear
WOOCS 2.2.1

Neuromodulation is one of the fastest growing sectors of the medical device market. Neuromodulation is a rapidly evolving medical technique that provides symptomatic relief through the alteration, or modulation, of nerve system function. It works by either stimulating nerves to produce a natural biological response or by applying small doses of pharmaceutical agents directly to the site of action.

The market has significant potential for growth with the increasing global burden of neurological and cardiovascular disorders, especially in the emerging economies. The growth in emerging markets such as India and China will be driven by an aging population that will increase demand for newer treatment options for age-related diseases. India’s expanding economy is likely to see an increased wealth among the population, specifically within the middle class, which will cause an increased adoption of westernised lifestyles. Diseases such as obesity and coronary heart disease will therefore become more prevalent. The neuromodulation devices market in the emerging economies will also benefit from a rise in demand for non-invasive treatment options and medical tourism. Growth in this market will also be driven by the approval and launch of neuromodulation devices that are more effective and involve a more simplified, less-invasive implantation procedure.

Neuromodulation Devices: World Market Prospects 2013-2023 analyses the top 4 companies involved in the neuromodulation devices market. This report also provides sales forecasts, market share analyses, discussions of technological developments and analyses of commercial drivers and restraints, including SWOT analysis of the overall neuromodulation devices market. There are 75 tables and figures included. The result is comprehensive profiles on the leading companies operating in the neuromodulation devices market with detailed analyses and informed opinion to benefit your work. Visiongain has determined that the value of the global Neuromodulation Devices Market will reach $12.45bn in 2023.

What makes this report unique?

Visiongain consulted widely with industry experts and full transcripts from these exclusive interviews are included in the report. As such, our reports have a unique blend of primary and secondary sources providing informed opinion. The report provides insight into key drivers and restraints facing the industry, as well as identifying leading companies. The report also provides a unique blend of qualitative analysis combined with extensive quantitative data including global, submarket and national market forecasts from 2012-2023 – all highlighting key business opportunities.

Why you should buy Neuromodulation Devices: World Market Prospects 2013-2023

• 111 pages of comprehensive analysis
• 2 Exclusive Visiongain interviews with experts from-
– Cochlear Ltd
– a US-based Medical Device Company (views provided anonymously)
• 75 tables, charts, and graphs
• Neuromodulation Device market forecasts between 2012-2023
• 3 Neuromodulation Device submarket forecasts from 2012-2023
– Spinal Cord Stimulation (SCS)
– Deep Brain Stimulation (DBS)
– Vagus Nerve Stimulation (VNS)
• A SWOT analysis
• Several leading companies identified and 4 profiled –
– Medtronic
– St. Jude Medical
– Boston Scientific
– Cyberonics

You can order this report today

Gain an understanding of the overall neuromodulation devices market and the leading companies operating in this market by ordering Neuromodulation Devices: World Market Prospects 2013-2023.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6 

To view free sample pages of this report please click here

Download sample pages

Complete the form below to download your free sample pages for Neuromodulation Devices: World Market Prospects 2013-2023


Download sample pages

Complete the form below to download your free sample pages for Neuromodulation Devices: World Market Prospects 2013-2023


Latest Pharma news

Visiongain publishes Constipation Nutraceuticals Market Report 2020-2030

Nutraceuticals are the products that provide medicinal and health benefits to the people. These products provide additional nutritional value to the foodstuff.

01 June 2020

READ

“Precision Medicine Market is Poised to Surpass US$67 billion in 2020” says new Visiongain report

Visiongain anticipates that the global precision medicine market is projected to witness a CAGR of 12% over the forecast period from 2020 to 2030. The global precision medicine market is anticipated to surpass US$ 67 billion in 2020 and is further projected to surpass US$ 200 billion in 2030.

27 May 2020

READ

Visiongain publishes Colon Targeting Drug Delivery Market Report 2020-2030

The global colon targeting drug delivery market is projected to grow at a CAGR of 8.07% in the first half of the forecast period. Visiongain anticipate that the global market will witness a CAGR of 9.23% during the forecast period 2020 to 2030.

27 May 2020

READ

“The global automation in biopharma market is estimated to reach USD 1.23 billion by 2025” says new Visiongain report

The automation in biopharma industry market is estimated to grow at a CAGR of 4.3% over the forecast period.

22 May 2020

READ

Categories

Category